Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Translational Development Acquisition (TDAC) Accounts Payables (2023 - 2026)

Translational Development Acquisition's Accounts Payables history spans 4 years, with the latest figure at $224323.0 for Q1 2026.

  • On a quarterly basis, Accounts Payables fell 0.51% to $224323.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $224323.0, a 0.51% decrease, with the full-year FY2025 number at $162311.0, up 902.6% from a year prior.
  • Accounts Payables came in at $224323.0 for Q1 2026, up from $162311.0 in the prior quarter.
  • The five-year high for Accounts Payables was $225477.0 in Q1 2025, with the low at $1252.0 in Q4 2023.
  • Historically, Accounts Payables has averaged $137650.7 across 4 years, with a median of $162920.0 in 2025.
  • Biggest five-year swings in Accounts Payables: surged 1193.05% in 2024 and later fell 0.51% in 2026.
  • Year by year, Accounts Payables stood at $1252.0 in 2023, then skyrocketed by 1193.05% to $16189.0 in 2024, then skyrocketed by 902.6% to $162311.0 in 2025, then surged by 38.21% to $224323.0 in 2026.
  • Business Quant data shows Accounts Payables for TDAC at $224323.0 in Q1 2026, $162311.0 in Q4 2025, and $171083.0 in Q3 2025.